Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: BrsaItaliana
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Molecular Medicine SPA

+ Add to Watchlist

MLM:IM

0.4736 EUR 0.0016 0.34%

As of 07:07:21 ET on 03/04/2015.

Snapshot for Molecular Medicine SPA (MLM)

Open: 0.4718 Day's Range: 0.4658 - 0.4770 Volume: 414,706
Previous Close: 0.4720 52wk Range: 0.4120 - 0.8080 1-Yr Rtn: -31.65%

Stock Chart for MLM

No chart data available.
  • MLM:IM 0.4735
  • 1D
  • 1M
  • 1Y
0.4720
Interactive MLM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MLM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 94.3400
Relative P/E vs. FTSEMIB -
Earnings Per Share (EUR) (ttm) -0.0758
Est. EPS (EUR) (12/2014) 0.0050
Est. PEG Ratio -
Market Cap (M EUR) 110.44
Shares Outstanding (M) 234.14
30 Day Average Volume 1,495,310
Price/Book (mrq) 13.2033
Price/Sale (ttm) 14.0320
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MLM

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MLM

Molecular Medicine SpA (MolMed) is a medical biotechnology company. The Company is focused on discovery, R&D, and clinical validation of innovative therapies for the treatment of cancer.

Claudio BordignonChairman/CEOMarina Del BueCo-General Manager
Germano CarganicoCo-General Manager
More Company Profile & Key Executives for MLM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil